LENACAPAVIR

Brand name:

• Sunlenca®

Pharmaceutical company:

GILEAD SCIENCES PTY LIMITED

Condition/indication:
(therapeutic use)

• Human immunodeficiency virus infection

PBAC Submission type:

New PBS listing (Category 1)

Comment:

--

Public Summary Document:

PBAC Public Summary Documents – November 2022

Related medicines:

--

Submission received for:

November 2022 PBAC meeting

Opportunity for consumer comment:

Open 27/07/2022 and close 21/09/2022 (see PBS Website)

PBAC meeting:

Held on 02/11/2022

PBAC outcome published:

Not Recommended (see PBAC Outcomes)

Lodgement of required documentation:

Not applicable

Agreement to listing arrangements:

Not applicable

Government processes:

Not applicable

Medicine listed on the PBS:

Not applicable

---